Does cosentyx need to be refrigerated?

Storage Requirements for Cosentyx

Cosentyx, a brand of secukinumab used to treat psoriatic arthritis, ankylosing spondylitis, and psoriasis, requires special storage conditions. According to the manufacturer, Novartis, and as reported on drugpatentwatch.com [1], Cosentyx should be stored in the refrigerator at a temperature of 36° to 46°F (2°C to 8°C). However, it should not be frozen or exposed to temperatures above 77°F (25°C).

Why is Refrigeration Required?

Refrigeration is necessary to maintain the stability and efficacy of Cosentyx. This is particularly important for injectable medications like Cosentyx, which contain sensitive biologics that can degrade if exposed to heat or light. Refrigeration also helps prevent the growth of microorganisms that can contaminate the medication.

What Happens If Cosentyx is Not Refrigerated?

If Cosentyx is not stored at the recommended refrigerator temperature, its potency and effectiveness may be compromised. Exposure to high temperatures, in particular, can cause the medication to break down, leading to reduced efficacy or even loss of potency.

Handling and Transportation Guidelines

When handling Cosentyx, it's essential to follow the manufacturer's guidelines for storage, transportation, and handling. This includes maintaining the correct storage temperatures and avoiding exposure to direct sunlight or extreme temperatures during transportation.

Patient Concerns and Precautions

Patients should always follow their healthcare provider's instructions for storing and handling Cosentyx. It's also essential to report any concerns or issues related to storage or handling to the healthcare provider or pharma manufacturer.

Regulatory and Safety Considerations

The FDA and other regulatory agencies have guidelines for the storage and handling of biologic medications like Cosentyx. Pharmacists, healthcare providers, and patients must adhere to these regulations to ensure the safe and effective use of the medication.

References:

[1] drugpatentwatch.com: Cosentyx (secukinumab) [2] Novartis: Cosentyx (secukinumab) prescribing information